Dallah Healthcare Résultats passés
Passé contrôle des critères 5/6
Dallah Healthcare a connu une croissance annuelle moyenne de ses bénéfices de 25.9%, tandis que le secteur Healthcare a vu ses bénéfices augmenter de en hausse à 20.3% par an. Les revenus ont augmenté de en hausse à un taux moyen de 21.2% par an. Le rendement des capitaux propres de Dallah Healthcare est 13.5% et ses marges nettes sont de 14.7%.
Informations clés
25.9%
Taux de croissance des bénéfices
23.2%
Taux de croissance du BPA
| Healthcare Croissance de l'industrie | 12.3% |
| Taux de croissance des recettes | 21.2% |
| Rendement des fonds propres | 13.5% |
| Marge nette | 14.7% |
| Dernière mise à jour des bénéfices | 30 Sep 2024 |
Mises à jour récentes des performances passées
Recent updates
Some Shareholders Feeling Restless Over Dallah Healthcare Company's (TADAWUL:4004) P/E Ratio
Oct 31
The Return Trends At Dallah Healthcare (TADAWUL:4004) Look Promising
Oct 07Do Dallah Healthcare's (TADAWUL:4004) Earnings Warrant Your Attention?
Sep 19Dallah Healthcare Company (TADAWUL:4004) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year
Aug 14The Price Is Right For Dallah Healthcare Company (TADAWUL:4004)
Jul 18Investors Will Want Dallah Healthcare's (TADAWUL:4004) Growth In ROCE To Persist
May 30We Ran A Stock Scan For Earnings Growth And Dallah Healthcare (TADAWUL:4004) Passed With Ease
Apr 16What You Can Learn From Dallah Healthcare Company's (TADAWUL:4004) P/E
Mar 18Returns On Capital At Dallah Healthcare (TADAWUL:4004) Have Hit The Brakes
Feb 25Dallah Healthcare (TADAWUL:4004) Has More To Do To Multiply In Value Going Forward
Oct 30Dallah Healthcare (TADAWUL:4004) Is Reinvesting At Lower Rates Of Return
Jul 26Returns On Capital Signal Tricky Times Ahead For Dallah Healthcare (TADAWUL:4004)
Apr 17Is Now The Time To Put Dallah Healthcare (TADAWUL:4004) On Your Watchlist?
Feb 06Dallah Healthcare (TADAWUL:4004) Will Want To Turn Around Its Return Trends
Dec 05We Ran A Stock Scan For Earnings Growth And Dallah Healthcare (TADAWUL:4004) Passed With Ease
Nov 01Calculating The Intrinsic Value Of Dallah Healthcare Company (TADAWUL:4004)
Aug 28Dallah Healthcare (TADAWUL:4004) Has Some Way To Go To Become A Multi-Bagger
Aug 12Here's Why We Think Dallah Healthcare (TADAWUL:4004) Is Well Worth Watching
Jul 28Industry Analysts Just Upgraded Their Dallah Healthcare Company (TADAWUL:4004) Revenue Forecasts By 10%
May 26Calculating The Fair Value Of Dallah Healthcare Company (TADAWUL:4004)
May 20Here's Why We Think Dallah Healthcare (TADAWUL:4004) Is Well Worth Watching
Apr 16Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively
Feb 03Is Now The Time To Put Dallah Healthcare (TADAWUL:4004) On Your Watchlist?
Jan 10Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively
Oct 19Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively
Jul 09Forecast: Analysts Think Dallah Healthcare Company's (TADAWUL:4004) Business Prospects Have Improved Drastically
Jun 16Broker Revenue Forecasts For Dallah Healthcare Company (TADAWUL:4004) Are Surging Higher
May 02What Kind Of Shareholders Hold The Majority In Dallah Healthcare Company's (TADAWUL:4004) Shares?
Mar 17Has Dallah Healthcare (TADAWUL:4004) Got What It Takes To Become A Multi-Bagger?
Mar 02Dallah Healthcare (TADAWUL:4004) Shareholders Booked A 45% Gain In The Last Year
Feb 15Should You Buy Dallah Healthcare Company (TADAWUL:4004) For Its Dividend?
Feb 01Are Dallah Healthcare's (TADAWUL:4004) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Jan 05
Dallah Healthcare Company's (TADAWUL:4004) Intrinsic Value Is Potentially 26% Below Its Share Price
Dec 22Will Dallah Healthcare (TADAWUL:4004) Multiply In Value Going Forward?
Nov 20Ventilation des recettes et des dépenses
Comment Dallah Healthcare gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 30 Sep 24 | 3,203 | 471 | 591 | 0 |
| 30 Jun 24 | 3,105 | 444 | 580 | 0 |
| 31 Mar 24 | 3,010 | 385 | 565 | 0 |
| 31 Dec 23 | 2,943 | 360 | 549 | 0 |
| 30 Sep 23 | 2,831 | 325 | 516 | 0 |
| 30 Jun 23 | 2,682 | 270 | 487 | 0 |
| 31 Mar 23 | 2,595 | 286 | 456 | 0 |
| 31 Dec 22 | 2,488 | 274 | 443 | 0 |
| 30 Sep 22 | 2,370 | 305 | 464 | 0 |
| 30 Jun 22 | 2,313 | 311 | 450 | 0 |
| 31 Mar 22 | 2,220 | 289 | 434 | 0 |
| 31 Dec 21 | 2,105 | 259 | 416 | 0 |
| 30 Sep 21 | 1,935 | 202 | 402 | 0 |
| 30 Jun 21 | 1,742 | 206 | 371 | 0 |
| 31 Mar 21 | 1,498 | 165 | 331 | 0 |
| 31 Dec 20 | 1,318 | 132 | 307 | 0 |
| 30 Sep 20 | 1,257 | 150 | 277 | 0 |
| 30 Jun 20 | 1,207 | 123 | 272 | 0 |
| 31 Mar 20 | 1,246 | 131 | 287 | 0 |
| 31 Dec 19 | 1,252 | 147 | 286 | 0 |
| 30 Sep 19 | 1,227 | 110 | 304 | 0 |
| 30 Jun 19 | 1,206 | 115 | 295 | 0 |
| 31 Mar 19 | 1,193 | 119 | 293 | 0 |
| 31 Dec 18 | 1,181 | 142 | 286 | 0 |
| 30 Sep 18 | 1,189 | 172 | 281 | 0 |
| 30 Jun 18 | 1,203 | 217 | 274 | 0 |
| 31 Mar 18 | 1,218 | 268 | 260 | 0 |
| 31 Dec 17 | 1,212 | 295 | 246 | 0 |
| 30 Sep 17 | 1,202 | 284 | 254 | 0 |
| 30 Jun 17 | 1,180 | 268 | 265 | 0 |
| 31 Mar 17 | 1,181 | 252 | 275 | 0 |
| 31 Dec 16 | 1,163 | 225 | 288 | 0 |
| 30 Sep 16 | 1,122 | 228 | 264 | 0 |
| 30 Jun 16 | 1,073 | 194 | 255 | 0 |
| 31 Mar 16 | 1,030 | 175 | 249 | 0 |
| 31 Dec 15 | 985 | 165 | 231 | 0 |
| 30 Sep 15 | 948 | 161 | 219 | 0 |
| 30 Jun 15 | 917 | 156 | 211 | 0 |
| 31 Mar 15 | 892 | 154 | 206 | 0 |
| 31 Dec 14 | 859 | 147 | 201 | 0 |
| 30 Sep 14 | 831 | 149 | 203 | 0 |
| 30 Jun 14 | 805 | 149 | 194 | 0 |
| 31 Mar 14 | 773 | 138 | 184 | 0 |
| 31 Dec 13 | 750 | 137 | 182 | 0 |
Des revenus de qualité: 4004 a des bénéfices de haute qualité.
Augmentation de la marge bénéficiaire: Les marges bénéficiaires nettes actuelles de 4004 sont plus élevées que l'année dernière 4004. (14.7%) sont plus élevées que l'année dernière (11.5%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: Les bénéfices de 4004 ont augmenté de manière significative de 25.9% par an au cours des 5 dernières années.
Accélération de la croissance: La croissance des bénéfices de 4004 au cours de l'année écoulée ( 44.9% ) dépasse sa moyenne sur 5 ans ( 25.9% par an).
Bénéfices par rapport au secteur d'activité: La croissance des bénéfices 4004 au cours de l'année écoulée ( 44.9% ) a dépassé celle du secteur Healthcare 15.7%.
Rendement des fonds propres
ROE élevé: Le retour sur capitaux propres de 4004 ( 13.5% ) est considéré comme faible.